Clinical Trial

Safe Zone in Trigger Point Injection

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 29, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to define the safe distance that will reduce the risk of pneumothorax through ultrasonographic imaging measurements in both sitting and prone positions to ensure patient safety during these procedures. The main question\[s\] it aims to answer \[is/are\]: The mean distance between the skin and pleura in sitting position during the inhalation and exhalation The mean distance between the skin and pleura in prone position during the inhalation and exhalation
Trial Details
NCT Number NCT06664359
Lead Sponsor Ankara University
Conditions Trigger Point Pain, Myofascial
Enrollment 211 participants
Start Date 2024-10-01
Primary Completion 2024-12-30 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-29